Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 6, 2010, Pages

  Raina, Hema ^a   Zhang, Qingli ^a,b   Rhee, Albert Y ^a,c   Pallone, Thomas L ^a   Wier, W Gil ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Active Diagnostics Inc   (United States)

^c Synchrogenix Information Strategies Inc   (United States)

Author keywords

Mesenteric; Neuropeptide Y; Neurotransmitters; Renal interlobar artery; Sympathetic nerve activity

Indexed keywords

CARBON FIBER; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NORADRENALIN; OUABAIN; PRAZOSIN;

AMPEROMETRY; ANIMAL CELL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTERY WALL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MESENTERIC ARTERY; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RENAL ARTERY; SALT INTAKE; SMOOTH MUSCLE; SYMPATHETIC NERVE; SYMPATHETIC TONE; VASOCONSTRICTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGICAL PHENOMENA; ENDOTHELIUM, VASCULAR; MESENTERIC ARTERIES; MODELS, ANIMAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77952624088     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01045.2009     Document Type: Article

References (58)

1. Aileru AA, De Albuquerque A, Hamlyn JM, Manunta P, Shah JR, Hamilton MJ, Weinreich D. Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 281: R635-R644, 2001. (Pubitemid 32756159)
2. +. Am J Physiol Heart Circ Physiol 279: H679-H691, 2000.
3. +-pump in human mesenteric arteries. J Hypertens 16: 1953-1958, 1998.
4. Boulanger BR, Lilly MP, Hamlyn JM, Laredo J, Shurtleff D, Gann DS. Ouabain is secreted by the adrenal gland in awake dogs. Am J Physiol Endocrinol Metab 264: E413-E419, 1993. (Pubitemid 23103954)
5. Brock JA, Bridgewater M, Cunnane TC. Beta-adrenoceptor mediated facilitation of noradrenaline and adenosine 5′-triphosphate release from sympathetic nerves supplying the rat tail artery. Br J Pharmacol 120: 769-776, 1997. (Pubitemid 27122714)
6. Byku M, Macarthur H, Westfall TC. Nerve stimulation induced over-flow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 295: H2188-H2197, 2008.
7. Cao C, Payne K, Lee-Kwon W, Zhang Z, Lim SW, Hamlyn J, Blaustein MP, Kwon HM, Pallone TL. Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat. Am J Physiol Renal Physiol 296: F98-F106, 2009.
8. Charkoudian N, Joyner MJ, Johnson CP, Eisenach JH, Dietz NM, Wallin BG. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 568: 315-321, 2005. (Pubitemid 41448640)
9. Chiba S, Yang XP. Neuroeffector mechanisms involved in the regulation of dog splenic arterial tone. J Pharmacol Sci 92: 84-92, 2003. (Pubitemid 36840809)
10. Christensen KL, Mulvany MJ. Location of resistance arteries. J Vasc Res 38: 1-12, 2001.
11. Dahlof C, Dahlof P, Lundberg JM. Neuropeptide Y (NPY): enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats. Eur J Pharmacol 109: 289-292, 1985. (Pubitemid 15141408)
12. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77: 75-197, 1997.
13. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100: 121-129, 2007.
14. 2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477-H485, 2005.
15. Dunn WR, Brock JA, Hardy TA. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br J Pharmacol 128: 174-180, 1999.
16. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70: 963-985, 1990. (Pubitemid 20364820)
17. Fedorova OV, Bagrov AY. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Am J Hypertens 10: 929-935, 1997.
18. Fedorova OV, Doris PA, Bagrov AY. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 20: 581-591, 1998.
19. Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 25: 1834-1844, 2007.
20. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86: 420-425, 1992.
21. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31: 68-72, 1998. (Pubitemid 28124694)
22. Haddy FJ. Role of dietary salt in hypertension. Life Sci 79: 1585-1592, 2006.
23. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263, 1991. (Pubitemid 21914926)
24. Huang BS, Cheung WJ, Wang H, Tan J, White RA, Leenen FH. Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats. Am J Physiol Heart Circ Physiol 291: H1109-H1117, 2006. (Pubitemid 44343654)
25. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous β and γENaC. Am J Physiol Renal Physiol 291: F1184-F1191, 2006.
26. Jernigan NL, Drummond HA. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol 289: F891-F901, 2005.
27. Khalil RA. Dietary salt and hypertension: new molecular targets add more spice. Am J Physiol Regul Integr Comp Physiol 290: R509-R513, 2006.
28. 2+ transients (jCaTs) in rat small arteries. Circ Res 91: 454-456, 2002.
29. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135: 794-797, 1994. (Pubitemid 24241265)
30. Leenen FH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101: 221-223, 2007.
31. Liang M, Cai T, Tian J, Qu W, Xie ZJ. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J Biol Chem 281: 19709-19719, 2006. (Pubitemid 44035473)
32. Lundberg JM, Pernow J, Tatemoto K, Dahlof C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand 123: 511-513, 1985. (Pubitemid 15038877)
33. 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand 120: 477-479, 1984.
34. Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 290: R553-R559, 2006.
35. Manunta P, Hamilton J, Rogowski AC, Hamilton BP, Hamlyn JM. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23, Suppl: S77-S85, 2000.
36. McGregor DD. The effect of sympathetic nerve stimulation of vasocon-strictor responses in perfused mesenteric blood vessels of the rat. J Physiol 177: 21-30, 1965.
37. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403: 86-89, 2000. (Pubitemid 30038526)
38. Pittner J, Rhinehart K, Pallone TL. Ouabain modulation of endothelial calcium signaling in descending vasa recta. Am J Physiol Renal Physiol 291: F761-F769, 2006. (Pubitemid 44506972)
39. Ponte A, Marin J, Arribas S, Gonzalez R, Barrus MT, Salaices M, Sanchez-Ferrer CF. Endothelial modulation of ouabain-induced contraction and sodium pump activity in aortas of normotensive Wistar-Kyoto and spontaneously hypertensive rats. J Vasc Res 33: 164-174, 1996. (Pubitemid 26089634)
40. Ponte A, Sanchez-Ferrer CF, Hernandez C, Alonso MJ, Marin J. Effect of ageing and hypertension on endothelial modulation of ouabain-induced contraction and sodium pump activity in the rat aorta. J Hypertens 14: 705-712, 1996. (Pubitemid 26187404)
41. 2+ exchanger impairs arteriolar myogenic reactivity. J Physiol 586: 1669-1681, 2008.
42. Rossi G, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens 13: 1181-1191, 1995.
43. Rummery NM, Brock JA, Pakdeechote P, Ralevic V, Dunn WR. ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J Physiol 582: 745-754, 2007. (Pubitemid 47040557)
44. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293: C509-C536, 2007. (Pubitemid 47235171)
45. --coupled neurotransmitter transporters-why amphetamines take two to tango. J Neurochem 112: 340-355, 2010.
46. Stjarne L. Novel dual "small" vesicle model of ATP- and noradrenaline-mediated sympathetic neuromuscular transmission. Auton Neurosci 87: 16-36, 2001.
47. +-loaded peripheral sympathetic nerves. Neurochem Int 53: 338-345, 2008.
48. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, Bianchi G, Manunta P. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 21: 1475-1481, 2003. (Pubitemid 36994125)
49. Weiss DN, Podberesky DJ, Heidrich J, Blaustein MP. Nanomolar ouabain augments caffeine-evoked contractions in rat arteries. Am J Physiol Cell Physiol 265: C1443-C1448, 1993. (Pubitemid 2015595)
50. Wier WG, Morgan KG. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Rev Physiol Biochem Pharmacol 150: 91-139, 2003.
51. 2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y. Exp Physiol 94: 31-37, 2009.
52. +-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 3: 157-168, 2003.
53. Yamazaki T, Akiyama T, Kawada T. Effects of ouabain on in situ cardiac sympathetic nerve endings. Neurochem Int 35: 439-445, 1999. (Pubitemid 29438572)
54. Yang XP, Chiba S. Separate modulation of neuropeptide Y1 receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic artery. J Cardiovasc Pharmacol 38, Suppl 1: S17-S20, 2001. (Pubitemid 33104678)
55. Zhang J, Hamlyn JM, Karashima E, Raina H, Mauban JR, Izuka M, Berra-Romani R, Zulian A, Wier WG, Blaustein MP. Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance. Am J Physiol Heart Circ Physiol 297: H1140-H1150, 2009.
56. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243-256, 2005.
57. 2+ ATPase in posttetanic potentiation at crayfish neuromuscular junctions. J Neurosci 21: 9598-9607, 2001.
58. Zukowska Z, Pons J, Lee EW, Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 81: 89-94, 2003. (Pubitemid 36398880)